A Unique Approach to Treating Neuromuscular Disorders
Tivorsan Pharmaceuticals is a protein therapeutics company pioneering a unique approach to treat serious neuromuscular disorders, including Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD).
- Tivorsan Pharmaceuticals Names Business Leader James E. Connolly as CEO and Board Member
- Tivorsan Pharmaceuticals to Present at Biotech Showcase™ 2015 on Monday, January 12
- Tivorsan Pharmaceuticals Achieves Key Development Milestones under its Parent Project Muscular Dystrophy and Muscular Dystrophy Association Awards